Single-Use Applications 2015

Join us for Single-Use Applications 2015 to learn how to optimize time-to-market, overcome complex drug product and manufacturing challenges, and ensure successful implementation and integrity of single-use adoption and deployment.

The event features 10 Case Studies and 2 Interactive Q&A Sessions on Today's Most Pressing Single-Use Challenges including:

• • Ensuring Successful Single-Use Implementation and Integrity: Case Studies from: Amgen and Merck & Co.
• • Single-Use Implementation and Transfer: Case Studies from: Genentech, Merck & Co. and Public Health England
• • BPSA Roundtable: Interactive Q&A: The Road Ahead: Issues Impacting the Accelerated Adoption of Single-Use Technologies
• • Single-Use Considerations for Cell Culture Applications: Case Studies from: NIH and Shire
• • Single-Use Applications in Upstream Processing: Case Studies from: Shire HGT and KPI Biopharma
• • Production and Regulatory Considerations for Single-Use: Case Study from: Protein Sciences Corp.
• • Overcoming Challenges Associate with Particles and Extractables & Leachables: Interactive Q&A: Extractables & Leachables

>> View the Single-Use Agenda
>> View the Full BDP Week Agenda
>> View the Agenda-a-Glance (PDF)

Single-Use Applications 2015 will take place from March 30-31, 2015 in Huntington Beach, CA.  It Flexible Facilities & Biopharmacuetical Development & Production Week is co-located with taking place on March 30 - April 2, 2015.

Share this article with your social network, just click below to share now!

Share |

Biopharmaceutical Development & Production Week 2015 > Call for Speakers

Biopharmaceutical Development and Production Week 2015 will be the most in-depth and comprehensive concept-to-commercialization experience for professionals dedicated to the advancement of next-generation biologics via manufacturing facilities of the future. And for the first time, BPD Week will also incorporate IBC’s Single-Use Applications and Flexible Facilities conferences into the event. Take a greater role in this community, add to your professional accomplishments, and help shape the future of the field by presenting a talk at BDP Week.

BioPharmaceutical Development and Production Week will take place March 30-April 2, 2015 in Huntington Beach, California.

Speaker proposals are being accepted now through October 27, 2014.
>> Submit your speaking proposal here.

If you are working in any of the following scientific/business topic areas, we encourage you to submit a proposal for a podium presentation. We are especially looking for case studies with unpublished data on the following:

• • Manufacturing Efficiencies: Strategy & Technology
• • Upstream Processing
• • Downstream Processing
• • Antibody Drug Conjugate Development & Production
• • Engineering (Single-Use and Flexible Facilities)
• • Analytical
• • Process Validation
• • Viral Safety
• • Raw Materials and Supply Chain

To go in-depth on what we’re looking for in each of these categories, visit our webpage.

How else can you get involved in BDP Week?

• • We’re also accepting abstracts for posters. Showcase your research by submitting your poster.
• • We’re also currently recruiting sponsors and exhibitors. Each year, BDP Week debuts as the first must attend event for biopharmaceutical professionals from around the globe. Now is the time, to work with IBC to develop a customized, integrated marketing program that features pre-, post- and on-site solutions that help increase your market reach and influence – before, during and after the event. Request more information. 
• • You can also join us as an attendee.  Registration is currently open and you can save up to $450 off the current rate.  

Have any questions? Feel free to reach out Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |

BioProcess International (BPI) 2014 Opens its Doors to More than 1500 Industry Leaders Seeking New Technologies, Partnerships, and Critical insights

Today IBC Life Sciences, is pleased to kick off the 2014 edition of BioProcess International Conference & Exhibition, the world’s largest event dedicated to biological development and manufacturing. Being held at the Hynes Convention Center in Boston from October 20-23, this year’s event will see more than 1500 industry professionals from across the biological development value chain to engage in intensive learning, networking and partnering.

“We are pleased to see that some of the industry’s leading companies have chosen to showcase their new products in the highly anticipated BPI Theater this year. The continued success of the BioProcess International Conference & Exhibition is due to the unwavering commitment of the sponsors, exhibitors, speakers and the attendees who ultimately help to cure disease and improve lives,” said Elizabeth Cutler, Managing Director, IBC Life Sciences.

The event opens with five visionary keynote presentations by John G. Cox, Executive Vice President, Pharmaceutical Operations & Technology, Biogen Idec; Robert Mattaliano, Ph.D., Group Vice President and Head of Biologics, Sanofi-Genzyme R&D Center; and, Geoffrey Ling, M.D., Ph.D., Director, Biological Technologies Office, DARPA.

The four main conference tracks are: cell culture & upstream processing, recovery & purification, manufacturing strategy, formulation & delivery and analytical & quality. These take place on October 21-23.

Plus, IBC will hold pre-conference symposiums on October 20, four bioprocessing professional development training courses on October 20-21 and the new success factors for early stage bilogics and early stage companies session on October 22.

The exhibit hall is open October 21-23 and features 150 exhibitors, the BPI Theater, lounges sponsors by SAFC, Pall Life Sciences and HETIRISK and the emerging marketplace pavilion.
New the year, the BPI Theater located in the exhibit hall (October 22-23) opens with an impressive lineup of new product launches from leading companies including, Meissner Filtration Products, Pall Life Sciences, EMD Millipore, Asahi Kasei Bioprocess, Sartorious Stedim and Purolite.

A high level of productive networking is anticipated by the strong adoption by this year’s attendees of partnering360 event specific networking tool. This new networking tool will make identifying and engaging with best-fit partners at the event easier than ever before.

Plus, the event will be the ideal backdrop to host the BioProcess International 2014 Industry Awards which celebrate and recognize the outstanding people, organizations and technologies that have significantly changed, impacted, and advanced the efficiency of biotherapeutic development and manufacturing process.

We're also onsite covering the event through our social media channels.  Follow #BPIConf on twitter for session updates and visit this blog each morning for a recap of each day's top sessions.

Share this article with your social network, just click below to share now!

Share |

BioProcess International Conference and Exhibition Starts Next Week!

Next week, over 1,500 bioprocess professionals are gathering in Boston for the industry's #1 bioprocessing event at BioProcess International Conference and Exhibition. Four days of content will will focus on cell culture & upstream processing, recovery & purification, biologics manufacturing strategies, analytical and quality, and formulation and drug delivery. Who else has registered to join us?

Here's some of the companies:

3M Purification, Abbvie. Alexion Pharmaceuticals Inc, Baxter Healthcare Corporation, BD Biosciences, Bio Rad Laboratories, BioProcess Technology Consultants, Bristol Myers Squibb, Chromatan Corporation, Corning Inc, EMD Millipore, Entegris, Eppendorf, Fujifilm Diosynth Biotechnologies, Genentech Incorporated, Hydranautics, Integra Companies Inc, JNC Corporation, Lonza, Merck & Co Inc, Momenta Pharmaceuticals, North Carolina State University, Parker Domnick Hunter, Progentics, Regeneron Pharmaceuticals, SAFC Biosciences, Shire, Takeda Pharmaceutical, United Therapeutics Corporation, VWR International LLC, WuXi AppTec

See a more comprehensive list at the webpage.

Want to join us?  As a reader of this blog, you can still save 20% off standard rates!  Register with priority code BPI14BLOG.  Have any questions?  Email me at jpereira@iirusa.com

Share this article with your social network, just click below to share now!

Share |

What’s Next in Cell Culture & Upstream Processing?

This fall at BioProcess International, we have a track dedicated to Cell Culture & Upstream Processing.  When you join us to learn about this topic, find out more about proven approaches and technologies to reduce timelines and increase efficiency and productivity.

This October in Boston, we look at

• ● Genomic Tool Implementation
• ● Synthetic Biology Applications
• ● Implementing Continuous Processing for Manufacturing
• ● Commercial Single-Use Applications
• ● Process Intensification
• ● Raw Material Integrity Testing
• ● Media Development and Optimization
• ● Small Scale Models and Tech Transfers

Companies have experienced many recent achievements to improve quality, cost, efficiency and productivity in cell culture, but what impact will the next wave of disruptive technologies and innovations have on biologics production?

Check Out These Key Case Studies & New Data Presentations Featured in these Informative Cell Culture & Upstream Processing Focused Sessions to Find Out: 

• • What's Next In Biologics Production New Data & Case Studies from: SAFC, Amgen and Lily Research Laboratories
• • Improving Product Quality & Control Case Study from: Amgen
• • Innovation at the Interface of Upstream & Downstream Production New Data & Case Studies from: FloDesign Sonic and Bioprocessing Technology Institute
• • Improving Efficiency, Productivity and Timelines in Cell Culture New Data & Case Studies from: Genentech, BioGen Idec and Fujifilm Diosynth Biotechnologies
• • Continuous Processing for Manufacturing (Sponsored by Novasep) New Data & Case Studies from: Sanofi Global Biotherapeutics, Merck & Co, The Pennsylvania State University and BioGen Idec
• • The Next Wave of Single Use Manufacturing: Closed Systems, New Technology and Cost Comparisons (Sponsored by: Life Technologies and Thermo Scientific) New Data & Case Studies from: Biogen Idec and Bayer Healthcare
• • Late Stage Cell Culture New Data & Case Studies from: Alexion Pharmaceuticals, AstraZeneca and Merck Research Labs
• • High-Throughput, QbD and DOE Approaches to Process Development New Data & Case Studies from: Genentech, Biogen Idec and Gallus Biopharmaceuticals

Plus, this Interactive Panel Discussion: How Well do you Know the Raw Materials Used in Your Upstream Manufacturing - Sponsored by BD Bioscience in the Impact of Raw Materials on Product session.

View the Complete Cell Culture Track Agenda

As a reader of this blog, when you register to join us at BioProcess International Conference and Exhibition this October 20-23 in Boston and mention code BPI14BLOG, you can save 20% off the standard rate.  Have any questions or need further information?  Feel free to reach out to Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |

Enabling Greater Process Control and Higher Protein Titers: Advances in Downstream Single-Use Technologies

Today, we feature an article from our partners at BioProcess International Magazine. This is an excerpt from the article Enabling Greater Process Control and Higher Protein Titers: Advances in Downstream Single-Use Technologies.

Enabling Greater Process Control and Higher Protein Titers: Advances in Downstream Single-Use Technologies

Downstream protein purification (the stage in which a protein is isolated and purified) is one of the last steps in biotherapeutic manufacturing. Single-use technologies are an increasingly popular choice for both upstream and downstream bioprocessing because they offer significant benefits over traditional multiuse manufacturing systems. Single-use technologies also provide an array of logistical benefits, including reduced costs, minimized risk of cross-contamination, and improved operational efficiency.

Challenges remain, however, in designing a complete, streamlined, single-use process for downstream protein purification. In-process sensor technologies, chromatography, and temperature control are all areas that have been traditionally underserved by single-use technologies and represent “weak points” in the downstream process flow. Exacerbating the problem, most proteins are heat labile and sensitive to a large number of environmental conditions. Therefore, interruptions in the process and improper temperature management can increase aggregation (which can lead to unstable formulations) or even degradation and denaturation in worst cases.

Read the full article here.


You can find out more about topics like this and meet and network with other professionals in the bioprocessing field at this year's BioProcess International Conference and Exhibition.  As a reader of this blog, when you register to join us October 20-23 in Boston, you are eligible to receive 20% off the standard rate when you mention code BPI14BLOG.

Share this article with your social network, just click below to share now!

Share |

Now Available: BDP Week 2014 Conference Brochure

We present the all new Biopharmaceutical Development and Production Week Agenda! This year, the event will take place March 24-27, 2013 in San Diego, California.

It features the most in-depth coverage of BioProcessing topics on the market including: Upstream Processing, Downstream Processing, Analytical Technologies, Viral Safety, Process Validation, Contract Manufacturing, Manufacturing Efficiencies, Supply Chain, Technology Transfer, Raw Materials, Antibody Drug Conjugates

Download the agenda.

What can you look forward to this year?

• - 6 Keynotes
• - 175+Speakers
• - 6 Interactive Discussions
• - 44 Case Studies
• - 59 New Data Presentations
• - 2 Day Training Courses
• - 65+ Exhibitors
• - 80+ Scientific Posters
• - 800+ Attendees
• - BDP Connect, the partnering app that allows to network before, during and after the event
• - Networking Opportunities including Mardi Gras Networking Reception, the BDP Week Beach Party and the Mexican Fiesta Networking Reception

As a reader of this blog, you can take advantage of unpublished rates! They are available until November 1. Simply register to join us and mention code BDP14BLOG to save up to $750 Off the All Access Pass Standard Rate or $450 of the 2 Day Standard Pass Rate. You can also register a team of 4 or more and save 20% off the current rate. The earlier your group registers, the more you save. Contact our group sales representative at 646-895-7445.

Have any questions about this event or how you can get involved? Email Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |

Call for Papers: Biopharmaceutical Development & Production (BDP) Week

Announcing IBC’s Annual Conference

Biopharmaceutical Development & Production (BDP) Week

March 24-27, 2014 • Hilton San Diego Bayfront Hotel • San Diego, CA

Now Accepting Speaking Proposals

Deadline to Submit is Friday, August 23rd - Submit Now

Program development is underway for IBC’s Biopharmaceutical Development & Production Week, which is happening March 24-27, 2014, at The Hilton Bayfront Hotel in San Diego, CA.

BDP Week, as it is known throughout the industry, is an event that professionals from every stage of bioprocessing have to come to rely on for new methods to navigate the development, production and regulatory challenges of mAbs and novel molecules.

Whether you are a research scientist or senior level executive, BDP Week is a must-attend calendar event for collective discussion on challenges and insights on the ever-evolving biopharmaceutical development and production sector.

Last February, nearly 1,000 gathered in Huntington Beach, CA, to gain new knowledge, network with industry leaders and discuss the future of bioprocessing. And they will do the same in San Diego in 2014, so why not share your thought leadership?

If you are working in any of the following scientific/business topic areas, we encourage you to submit proposal for a podium presentation. We are especially looking for case studies with unpublished data on the following:

• • ADC Development & Production
• • Antibody Development & Production - Upstream Processing
• • Antibody Development & Production - Downstream Processing
• • Contract Manufacturing & Technology Transfer
• • Analytical Technologies for Biotherapeutic Development
• • Raw Materials
• • Supply Chain Management & Transparency
• • Manufacturing Strategy: Operational Excellence, Business Process/Lifecycle Management
• • Manufacturing Technology Applications: Continuous, Flexible, Automated and Multi-Product
• • Viral Safety and Pathogen Safety for Biologics
• • Process Validation and Continuous Verification
• • Optimizing Properties of Biopharmaceuticals

Review the submission guidelines and to submit a presentation proposal. Deadline to submit is Friday, August 23.

If you would like to submit a proposal, but need an extension or have any topic suggestions, please contact Barry Walsh at 508-614-1464 , Michael Keenan at 949-276-2634 or Mark DeSorbo at 508-614-1405.

If your talk is accepted, you will receive a formal invitation to speak at the conference. This invitation will reflect a deadline for you to send a final presentation title and 60-word abstract. Your abstract and presentation must describe scientific results and must not contain marketing or business development content.

Share this article with your social network, just click below to share now!

Share |